Hepcidin may have potential to guide iron therapy in severely anaemic children because in this population there is diminished up regulation of hepcidin in inflammation and iron deficiency due to an increase in erythropoietin [17]. The gene discussed is HAMP; the disease is Iron deficiency anemia.